The goal of surveillance and management of patients with thyroid cancer who are at low risk
for recurrence is to avoid unnecessary testing, radiation exposure, and cost, whereas the …

BACKGROUND: Cervical recurrence occurs in up to 30% of patients after surgical treatment
for papillary thyroid cancer. This study sought to determine an appropriate algorithm for …

Thyroid cancer is one of the fastest growing diagnoses; more cases of thyroid cancer are
found every year than all leukemias and cancers of the liver, pancreas, and stomach. Most of …

Objective Because differentiated (follicular and papillary) thyroid cancer (DTC) may recur
years after initial treatment, the follow-up of patients with DTC is long term. However, this …

Multiple factors affect the long-term prognosis of thyroid malignancies (1), but outcome is
mainly decided by an interplay between the patient and tumor and by the impact of therapy …

Thyroid cancer is a common malignancy with an apparent increasing incidence and a wide
spectrum of clinical behavior and therapeutic responsiveness. Recent advances in …

Objective: Guidelines recommend thyroid-stimulating hormone (TSH) suppression before
the first response to treatment assessment in papillary thyroid cancer (PTC) patients. The …

Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Thyroid nodules are very common, and thyroid cancer is currently the fifth leading cancer
diagnosis in women. The American Thyroid Association has led the development and …

We are witnessing a rapid worldwide increase in the incidence of papillary thyroid
carcinoma (PTC) in the last thirty years. Extensive implementation of cancer screening and …